Dataset Information

Trypanosoma brucei global proteome changes upon suramin exposure

ABSTRACT: To understand how suramin kills Trypanosoma brucei, we examined the impact on proteome at different timepoints

INSTRUMENT(S): LTQ Orbitrap Velos, Q Exactive

ORGANISM(S): Trypanosoma Brucei

TISSUE(S): Permanent Cell Line Cell

DISEASE(S): Sleeping Sickness

SUBMITTER: Martin Zoltner

LAB HEAD: Mark C. Field

PROVIDER: PXD014215 | Pride | 2020-04-30

REPOSITORIES: Pride

ACCESS DATA

Dataset's files

Source:

Items per page:

1 - 5 of 51

Publications

Suramin exposure alters cellular metabolism and mitochondrial energy production in African trypanosomes.

Zoltner Martin M Campagnaro Gustavo D GD Taleva Gergana G Burrell Alana A Cerone Michela M Leung Ka-Fai KF Achcar Fiona F Horn David D Vaughan Sue S Gadelha Catarina C Zíková Alena A Barrett Michael P MP de Koning Harry P HP Field Mark C MC

The Journal of biological chemistry 20200430 24

Introduced about a century ago, suramin remains a frontline drug for the management of early-stage East African trypanosomiasis (sleeping sickness). Cellular entry into the causative agent, the protozoan parasite <i>Trypanosoma brucei</i>, occurs through receptor-mediated endocytosis involving the parasite's invariant surface glycoprotein 75 (ISG75), followed by transport into the cytosol via a lysosomal transporter. The molecular basis of the trypanocidal activity of suramin remains unclear, bu ...[more]

PMID: 32354742

Similar Datasets

Project description:Endometrial cancer (EC) is the most common cancer of female reproductive organs. Because some low-grade ECs might also experience tumor recurrence after surgery and a worse prognosis, the study of alterations related to EC pathogenesis of the disease might help to get insights into underlying mechanisms involved in EC development and metastasis and identify novel markers associated to the disease. Here, low C1GALT1 protein expression levels were associated to a more aggressive phenotype of EC. Then, we aimed at investigating the role of C1GALT1 in EC progression by quantitative proteomics. ECC-1 cells were used as endometrioid EC model, and the effect of C1GALT1 depletion was analyzed using C1GALT1 specific short hairpin RNAs (shRNA) in comparison to SCRAMBLE shRNA. SILAC and mass spectrometry analysis were performed to identify and quantify dysregulated proteins associated with C1GALT1 depletion in the cell extract and secretome proteome of shC1GALT1 and SCRAMBLE ECC-1 cells. Out of 5208 proteins identified and quantified by LC-MS/MS, 76 and 143 proteins showed dysregulation (fold-change ≥1.5 or ≤0.67) in shC1GALT1 ECC-1 cells’ extracts and secretome, respectively. Nine dysregulated proteins were selected for validation by orthogonal techniques, confirming their dysregulation upon C1GALT1 depletion. Bioinformatics analyses pointed out to an increase in pathways and dysregulated proteins that associated with more aggressive phenotype. This finding was corroborated by loss-of-function cell-based assays. A higher proliferation, invasion, migration, colony formation and angiogenesis capacity of C1GALT1 depleted cells was observed. Finally, the negative protein expression correlation found by proteomics between C1GALT1 and LGALS3 was confirmed by IHC in actual EC samples, suggesting C1GALT1 stably depleted ECC-1 cells mimic the aggressive phenotype of EC cells and might be useful for the identification and validation of potential markers in aggressive ECs.

			Action	DRS
	24-sur1.raw	Raw
	24-sur2.raw	Raw
	24-sur3.raw	Raw
	24-sur4.raw	Raw
	24-sur5.raw	Raw